{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:56:46Z","timestamp":1790265406819,"version":"4.1.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Brain <jats:sup>18<\/jats:sup>F-FDG uptake reportedly starts to decline more than 10 years before the onset of cognitive decline in dominantly inherited Alzheimer disease (AD). We compared longitudinal <jats:sup>18<\/jats:sup>F-FDG images in sporadic AD to aging data from a large sample size to expand the current knowledge of <jats:sup>18<\/jats:sup>F-FDG reduction for AD progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Participants comprised 2 individuals (subjects A and B at ages 65 and 68 years, respectively) and 107 control subjects (67.9 [SD, 4.9] years). Subject A underwent <jats:sup>18<\/jats:sup>F-FDG PET a total of 8 times over 9 years from the preclinical to early dementia stages. Subject B underwent <jats:sup>18<\/jats:sup>F-FDG PET a total of 11 times over 12 years from the preclinical to mild cognitive impairment stages. Control subjects underwent <jats:sup>18<\/jats:sup>F-FDG PET twice over a mean follow-up period of 7.8 years. After placing the volume of interest on the AD-related hypometabolic regions, the longitudinal <jats:sup>18<\/jats:sup>F-FDG images were compared among the subjects and control subjects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>For the control group, the rate of <jats:sup>18<\/jats:sup>F-FDG reduction was 2.2% per decade (ie, aging effects). The rates of <jats:sup>18<\/jats:sup>F-FDG reduction were 9.41% over 9 years and 9.07% over 12 years in subjects A and B, respectively. We estimated that <jats:sup>18<\/jats:sup>F-FDG uptake started to decrease 4 and 2 years before indications of memory loss in subjects A and B, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The present study suggests that the time between the beginning of <jats:sup>18<\/jats:sup>F-FDG reduction and the onset of cognitive decline may be shorter in elderly individuals with AD compared with the recently estimated period in dominantly inherited AD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002948","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:17:59Z","timestamp":1581538679000},"page":"e185-e189","source":"Crossref","is-referenced-by-count":16,"title":["Longitudinal 18F-FDG Images in Patients With Alzheimer Disease Over More Than 9 Years From a Preclinical Stage"],"prefix":"10.1097","volume":"45","author":[{"given":"Kenji","family":"Ishibashi","sequence":"first","affiliation":[{"name":"Research Team for Neuroimaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airin","family":"Onishi","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Wagatsuma","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Research Team for Social Participation and Community Health, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[{"name":"Research Team for Neuroimaging"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiol.2311021620","article-title":"Alzheimer disease: operating characteristics of PET\u2014a meta-analysis","volume":"231","year":"2004","journal-title":"Radiology"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome","volume":"286","year":"2001","journal-title":"JAMA"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejrad.2017.07.014","article-title":"The diagnostic value of FDG and amyloid PET in Alzheimer's disease\u2014a systematic review","volume":"94","year":"2017","journal-title":"Eur J Radiol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","year":"2010","journal-title":"Lancet Neurol"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging\u2013Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib6-20230925","first-page":"e1","article-title":"2014 Update of the Alzheimer's disease neuroimaging initiative: a review of papers published since its inception","volume":"11","year":"2015","journal-title":"Alzheimers Dement"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","year":"2018","journal-title":"Lancet Neurol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"e47905","DOI":"10.1371\/journal.pone.0047905","article-title":"Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.archger.2015.12.005","article-title":"Long-term effects of an intergenerational program on functional capacity in older adults: results from a seven-year follow-up of the REPRINTS study","volume":"64","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"11557","DOI":"10.1038\/s41598-018-29937-y","article-title":"Longitudinal effects of aging on 18F-FDG distribution in cognitively normal elderly individuals","volume":"8","year":"2018","journal-title":"Sci Rep"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging\u2013Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","article-title":"Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.2967\/jnumed.112.116137","article-title":"Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET","volume":"54","year":"2013","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:03:08Z","timestamp":1695621788000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002948","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,12]]}}}